Business Wire

http://au.biz.yahoo.com//071010/43/1fp5e.html

Eric Yu, CFO Benda Pharmaceutical, Inc., is the Featured Guest in an Audio Interview at SmallCapVoice.com

Wednesday October 10 1:26 PM

SmallCapVoice.com, Inc. today announced that a new audio interview featuring, Eric Yu, CFO of Benda Pharmaceutical, Inc., a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, is now available at SmallCapVoice.com. The interview can be heard here: http://www.smallcapvoice.com/bpma/bpma-10-9-07.php.

About Benda Pharmaceutical, Inc.

Benda Pharmaceutical, Inc. (www.bendapharma.com), a China-based pharmaceutical company, is a pure play on explosive Chinese pharmaceutical spending and the global search for a cancer cure. Benda produces traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

Safe Harbor Statement:

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements express or implied by such forward-looking statements. The forward-looking statements are subject to risks and uncertainties including, without limitation, changes in levels of competition, possible loss of customers, and the company's ability to attract and retain key personnel.

Print Me Now!  -  Back to Original Article